Takeda To Build $126 Million R&D Facility For Biopharmaceuticals
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical plans to build a research-and-development facility in Japan to develop biopharmaceuticals
Takeda Pharmaceutical plans to build a research-and-development facility in Japan to develop biopharmaceuticals. The $126 million facility is set to begin construction in July and be online in the fall of next year. Takeda said its R&D facility, to be built on the grounds of its Osaka production plant, would be used to develop low-cost ways to produce antibodies, nucleic-acid drugs and other biopharmaceuticals. (Click here for more - a subscription may be required) "Takeda To Build R&D Facility For Biopharm Tech" - Nikkei (Japan) (6/11/10) |